Radiometer strengthens its global Immunoassay Business in Turku

Radiometer announces that it will purchase its current facility in Turku and expand the site’s production and R&D capabilities, a move that will grow its global immunoassay business.

By moving from a lease agreement to ownership of the site, Radiometer is strengthening its global production and development activities to accommodate the future growth of its global immunoassay business.

“We are securing additional space to double the production and R&D space in Turku during the coming years to accommodate for the future growth of Radiometer Turku, and to keep a leading role in assay development” says Sebastian Kräemer, General Manager of Radiometer Turku Oy.

Sanna Wallenborg, Vice president and General Manager of Radiometer’s Immunoassay Business unit adds, “This is a very important milestone for our entire Immunoassay Business, securing that we can meet increasing customer demands and deliver on our growth strategy.”

Radiometer, founded in Denmark in 1935, introduced the world’s first commercially available blood gas analyzer, and their products and solutions provide information on critical parameters in acute care, supporting the diagnosis of critically ill patients. Radiometer Turku Oy develops, designs, and manufactures immunoassay test kits for immunoassay testing, including cardiac and infection biomarkers.

Following the investment into a new production line in Turku in 2021, the acquisition of the site is part of Radiometers multi-million Euro investment to secure the space needed to support their growth strategy. Half of the building has been rented and occupied by Radiometer for years. “The site will be equipped with the latest production technologies, including Artificial Intelligence and IoT, and I look forward to an exciting future ahead as we embark on this new chapter of our growth journey” Sebastian ends.

CBRE and Hannes Snellman acted as Radiometer’s advisors on the acquisition of the building.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Radiometer Medical. (2022, October 12). Radiometer strengthens its global Immunoassay Business in Turku. News-Medical. Retrieved on April 23, 2024 from

  • MLA

    Radiometer Medical. "Radiometer strengthens its global Immunoassay Business in Turku". News-Medical. 23 April 2024. <>.

  • Chicago

    Radiometer Medical. "Radiometer strengthens its global Immunoassay Business in Turku". News-Medical. (accessed April 23, 2024).

  • Harvard

    Radiometer Medical. 2022. Radiometer strengthens its global Immunoassay Business in Turku. News-Medical, viewed 23 April 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Radiometer and Etiometry Announce Partnership to Enhance Neonatal Intensive Care Clinical Workflows and Patient care